A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2024
DOI: 10.1016/j.saa.2024.124262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2024. Verfasst von Heba M Hashem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: hebamaher89@mans…. Hauptthemen laut MEDLINE: Imatinib Mesylate, Fluorescent Dyes, Molecularly Imprinted Polymers, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Myeloid leukemia is a chronic cancer, which associated with abnormal BCR-ABL tyrosine kinase activity. Imatinib (IMB) acts as a tyrosine kinase inhibitor and averts tumor growth in cancer cells by controlling cell division, so it is urgent to develop an effective assay to detect and monitor its IMB concentration. Therefore, an innovative fluorescent biomimetic sensor is a promising sensing material that constructed for the efficient recognition of IMB and displays excellent selectivity and sensitivity stemming from molecularly imprinted polymer@Fe3O4 (MIP@Fe3O4). The detection strategy depends on the recognition of IMB molecules at the imprinted sites in the presence of coexisting molecules, which are then transferred to the fluorescence signal. The synthesized MIP@Fe3O4 was characterized using Fourier-transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), and atomic force microscopy (AFM). Furthermore, computational studies of the band gap (EHOMO-ELUMO) of the monomers, IMB, and their complexes were performed. These results confirmed that the copolymer is the most appropriate and has high stability (Binding energy; 0.004 x 10-19 KJ) and low reactivity. A comprehensive linear response over IMB concentrations from 5 × 10-6 mol/L to 8 × 10-4 mol/L with a low detection limit of 9.3 × 10-7 mol/L was achieved. Furthermore, the proposed technique displayed long-term stability (over 2 months), high intermediate precision (RSD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: hebamaher89@mans.edu.eg.
- Chemistry Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.
- Pharmacology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Zitieren
APA
Hashem, H. M., Ghaith, E. A., Eladl, A., Abozeid, S. M., & Abdallah, A. B. (2024). A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2024.124262
Vancouver
Hashem HM, Ghaith EA, Eladl A, Abozeid SM, Abdallah AB. A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2024. doi:10.1016/j.saa.2024.124262
BibTeX
@article{Hashem2024,
author = {Hashem, Heba M and Ghaith, Eslam A and Eladl, Amira and Abozeid, Samira M and Abdallah, A B},
title = {A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2024},
doi = {10.1016/j.saa.2024.124262}
}
EUVIMED